Our work here provides evidence of a central role for PAI-1 in the platelet-cancer cell interactome, and demonstrates its potential as a biomarker, gauge of therapy response, prognostic indicator, therapeutic target, and guide to deciphering the molecular complexities of OC. Here, SERPINE1 is linked to cancer.